Novartis's $90 million Swiss factory to help solve cell therapy bottleneck

November 28, 2019 by  
Filed under News

Swiss drugmaker Novartis’s new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of its cell therapy Kymriah for cancer in 2020.

Source: Reuters Business News

Comments are closed.